Ping An Biomedical Co. Ltd. Held Shareholder Meeting to Approve Share Capital Changes

Reuters
Mar 19
<a href="https://laohu8.com/S/000001">Ping An</a> Biomedical Co. Ltd. Held Shareholder Meeting to Approve Share Capital Changes
  • Ping An Bio held its annual general meeting on March 18, 2026.
  • Shareholders approved changes to authorized share capital to USD 312,500 and the creation of Class B shares with 100 votes per share.
  • Adoption of a second amended and restated memorandum and articles of association was approved.
  • A share exchange was approved to repurchase 12.25 million Class A shares from InspireTech and issue 12.25 million Class B shares to InspireTech.
  • A share consolidation was approved, allowing the board to consolidate up to 1,000 Class A shares into 1 and up to 1,000 Class B shares into 1, with fractional entitlements rounded up.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603191000PRIMZONEFULLFEED9675208) on March 19, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10